What is Microbe Shield Worldwide?
Headquartered in Coconut Creek, Florida, Microbe Shield Worldwide operates as a specialized entity within the Chemicals and Related Products industry. With a lean workforce of 10 to 19 professionals, the company has demonstrated impressive fiscal efficiency, generating annual revenues in the range of 5M to 10M. The firm focuses on high-value chemical applications, carving out a niche that balances technical innovation with industrial utility. Its current market position is defined by a disciplined operational model that prioritizes sustainable growth and high-margin product delivery, making it a notable player in the regional chemical manufacturing landscape.
How much funding has Microbe Shield Worldwide raised?
Microbe Shield Worldwide has raised a total of $392K across 2 funding rounds:
Debt
$150K
Debt
$242K
Debt (2020): $150K with participation from PPP
Debt (2021): $242K led by PPP
Key Investors in Microbe Shield Worldwide
PPP
Public-Private Partnership
What's next for Microbe Shield Worldwide?
With the recent infusion of capital, Microbe Shield Worldwide is expected to transition into a phase of intensified market penetration and infrastructure optimization. The strategic deployment of these funds will likely target the expansion of production capabilities and the enhancement of supply chain resilience. As the company navigates this late-stage growth cycle, management will likely focus on scaling its core product offerings to meet rising industrial demand. Future milestones will center on operational efficiency gains and the potential for further market diversification, ensuring the firm remains competitive against larger, more established chemical conglomerates while maintaining its agile, high-revenue-per-employee profile.
See full Microbe Shield Worldwide company page
